Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCP2 | P22307 | 1/20 | 0.75 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.64 |
| ▸ | RAB9A | P51151 | 2/20 | 0.64 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3501312 | 0.92 | SCP2 (0.82) | SCP2POLBMEN1KMT2ANPC1 | |
| SCHEMBL26434823 | 0.92 | SCP2 (0.76) | SCP2POLBMEN1KMT2ANPC1 | |
| SCHEMBL19646592 | 0.89 | SCP2 (0.77) | SCP2POLBMEN1KMT2ANPC1 | |
| SCHEMBL62370 | 0.87 | SCP2 (0.77) | SCP2POLBMEN1KMT2ANPC1 | |
| SCHEMBL16812947 | 0.87 | SCP2 (0.74) | SCP2POLBMEN1KMT2ANPC1 | |
| SCHEMBL14267417 | 0.86 | SCP2 (1.00) | SCP2POLBMEN1KMT2ANPC1 | |
| SCHEMBL61656 | 0.85 | SCP2 (0.75) | SCP2POLBMEN1KMT2ANPC1 | |
| SCHEMBL7815701 | 0.85 | SCP2 (0.79) | SCP2POLBMEN1KMT2ANPC1 | |
| SCHEMBL25188913 | 0.84 | SCP2 (0.71) | SCP2POLBMEN1KMT2ANPC1 | |
| SCHEMBL7812704 | 0.84 | SCP2 (0.93) | SCP2POLBMEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11639929-B2 | Universal histidine-tag binding compounds and methods of use thereof as fluorescent probes and sensors | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639929-B2 | Universal histidine-tag binding compounds and methods of use thereof as fluorescent probes and sensors | HCLS1, PHF6, PHPT1 | SCP2 3784/4885POLB 4855/4885MEN1 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.